- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/36 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class A61K 38/36
Total number of patents in this class: 1113
10-year publication summary
|
76
|
83
|
75
|
74
|
66
|
55
|
63
|
46
|
46
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2715 |
32 |
| Bioverativ Therapeutics Inc. | 215 |
27 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
25 |
| CSL Behring GmbH | 352 |
24 |
| The Children's Hospital of Philadelphia | 830 |
21 |
| Baxter International Inc. | 2199 |
17 |
| Baxter Healthcare S.A. | 1652 |
17 |
| RegenLab USA LLC | 78 |
16 |
| Ethicon, Inc. | 1147 |
14 |
| Omrix Biopharmaceuticals Ltd. | 153 |
14 |
| KM Biologics Co., Ltd | 96 |
13 |
| Quiapeg Pharmaceuticals AB | 41 |
12 |
| The Regents of the University of California | 20427 |
10 |
| Mayo Foundation for Medical Education and Research | 3340 |
10 |
| Asahi Kasei Pharma Corporation | 118 |
10 |
| Modernatx, Inc. | 1283 |
10 |
| Octapharma AG | 203 |
10 |
| Combangio, Inc. | 28 |
9 |
| The Board of Trustees of the University of Illinois | 2736 |
8 |
| Emory University | 1688 |
8 |
| Other owners | 806 |